ALEXANDRIA, Va., Feb. 12 -- United States Patent no. 12,221,416, issued on Feb. 11, was assigned to Morphic Therapeutic Inc. (Waltham, Mass.).
"Antagonists of human integrin Alpha4Beta7" was invented by Matthew G. Bursavich (Needham, Mass.), Dawn M. Troast (Bedford, Mass.), Bryce A. Harrison (Framingham, Mass.), Blaise S. Lippa (Newton, Mass.), Bruce N. Rogers (Belmont, Mass.), Kyle D. Konze (Brooklyn, N.Y.), Aleksey I. Gerasyuto (Flemington, N.Y.), Tyler Day (New York), Fu-Yang Lin (Sudbury, Mass.), Kristopher N. Hahn (Medford, Mass.), Mats A. Svensson (New York), Byungchan Kim (West New York, N.Y.), Cheng Zhong (Belmont, Mass.), Alexey A. Lugovskoy (Belmont, Mass.) and Brian Sosa (Cambridge, Mass.).
According to the abstract* released b...